Home » Archive

News

News, Syndication, Xconomy »

Xconomist of the Week: Roger Perlmutter’s Parting Thoughts on Amgen

Posted by sandiegobiotech March 1st, 2012 .
No Comments

[Updated: 1:50 pm PT] Roger Perlmutter had a long run by biotech standards, a full 11 years, to put his stamp on R&D at Amgen. Some of the work he oversaw was unequivocally good (denosumab for…

[[Click headline to continue reading.]]

More...

Marketwire, News, Syndication »

Quidel Reports Fourth Quarter and Full Year 2011 Financial Results

Posted by Mary Canady February 29th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Feb 29, 2012) – Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, announced today financial results for the fourth quarter and full year ended…

More...

Marketwire, News, Syndication »

Ardea Biosciences to Present at Upcoming Investor Conferences

Posted by Mary Canady February 29th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Feb 29, 2012) – Ardea Biosciences, Inc. (NASDAQ: RDEA) announced today that Barry D. Quart, PharmD, president and chief executive officer, will present at the following upcoming investor conferences in March 2012:

More...

News, Syndication, Xconomy »

Concert Nabs $200M Deal From Avanir to Make Psych Drugs

Posted by sandiegobiotech February 29th, 2012 .
No Comments

Lexington, MA-based Concert Pharmaceuticals has found a second partner looking to take advantage of its technology for making deuterium-modified drugs. Concert is announcing today that Aliso Viejo,…

[[Click headline to continue reading.]]

More...

Marketwire, News, Syndication »

Senomyx, Inc. Fourth Quarter and Fiscal Year-End 2011 Earnings Conference Call Scheduled for March 1, 2012

Posted by Mary Canady February 27th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Feb 27, 2012) – Senomyx, Inc. (NASDAQ: SNMX) will release its financial results for the fourth quarter and fiscal year ended December 31, 2011 on Thursday, March 1, 2012 before the opening of the U.S. financial markets. T…

More...

News, Syndication, Xconomy »

Bruce Booth, a LifeSciVC Shining Some Much-Needed Light on Biotech

Posted by sandiegobiotech February 27th, 2012 .
No Comments

Techies who want to learn about high-tech venture capital learn quickly they must read blogs by guys like Fred Wilson and Brad Feld. They are insiders who speak with clear, consistent, and insightful…

[[Click headline to continue reading.]]

More...

Marketwire, News, Syndication »

Avid Bioservices to Present at IBC’s Antibody Development and Production Conference

Posted by Mary Canady February 23rd, 2012 .
No Comments

TUSTIN, CA and SAN DIEGO, CA–(Marketwire – Feb 23, 2012) – Avid Bioservices, Inc., a leading provider of integrated biomanufacturing services and a subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), today announced that it will present t…

More...

News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Receptos, Vital Therapies, & More

Posted by sandiegobiotech February 23rd, 2012 .
No Comments

Funding deals accounted for much of the life sciences news over the past week. We’ve got it all wrapped up here. —San Diego-based Receptos, which is using the structure of cellular G protein-coupled…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Receptos, Vital Therapies, & More

Posted by sandiegobiotech February 23rd, 2012 .
No Comments

Funding deals accounted for much of the life sciences news over the past week. We’ve got it all wrapped up here. —San Diego-based Receptos, which is using the structure of cellular G protein-coupled…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Receptos, Vital Therapies, & More

Posted by sandiegobiotech February 23rd, 2012 .
No Comments

Funding deals accounted for much of the life sciences news over the past week. We’ve got it all wrapped up here. —San Diego-based Receptos, which is using the structure of cellular G protein-coupled…

[[Click headline to continue reading.]]

More...